A promising development in prostate cancer care: can immunotherapy help?
New research suggests that immunotherapy could potentially improve outcomes for patients with localized, high-risk prostate cancer when used alongside traditional treatments. However, experts emphasize that more clinical trials are required before it becomes a standard medical practice.
Why it matters
Advancements in cancer treatment offer hope for better disease control and improved quality of life for patients, though the efficacy of immunotherapy in this specific context remains under study.
A promising development in prostate cancer care: can immunotherapy help? left Immunotherapy could offer a new approach to treating localised, high-risk prostate cancer when combined with established treatments such as radiotherapy and hormone therapy. However, further research and follow-up are needed to establish its long-term benefits and determine whether it could become part of standard treatment |Image used for representational purpose only AFP AFP https://th-i.thgim.com/public/incoming/oyallb/article71600841.ece/alternates/FREE_1200/AFP_32T77YH.jpg JEFF PACHOUD (FILES) In this file photo taken on April 10, 2014 a surgeon sitting in front of screens of a Focal Onedevice performs a robot-assisted prostate tumorectomy using ultrasound imaging at the Edouard Herriot hospital in Lyon, center France. - Robots are becoming more and more important in hospitals, where they help track down tumors and change certain practices.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in